# Pharmacokinetics of Ceftaroline in Normal and Obese Subjects

> **NCT01648127** · PHASE1 · COMPLETED · sponsor: **Keith A. Rodvold** · enrollment: 32 (actual)

## Conditions studied

- Drug Safety

## Interventions

- **DRUG:** Ceftaroline

## Key facts

- **NCT ID:** NCT01648127
- **Lead sponsor:** Keith A. Rodvold
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2013-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01648127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01648127, "Pharmacokinetics of Ceftaroline in Normal and Obese Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01648127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*